Skip to content Skip to menu

Medicines industry recognised as ‘best employers’

Monday, 4 June 2012

Media Release

Medicines Australia congratulates two of its member companies, Janssen and Shire, who have won accreditation in the 2012 Aon Hewitt Best Employers in Australia and New Zealand Accreditation Program.

Jansen and Shire were among only 14 companies to be accredited in the annual program which is open to companies from all over Australia and New Zealand.

Medicines Australia chief executive Dr Brendan Shaw said the recognition of the two companies underscored the credentials of the Australian medicines industry as a great place to work.

“The fact that two members of the Australian medicines industry have been accredited by the Aon Hewitt Best Employers program, and judged to be among the best 13 companies on the continent in that respect speaks volumes for our industry,” Dr Shaw said.

“There are undoubted commercial advantages in encouraging a strong and positive workplace culture and providing employees with an attractive and appealing working environment, and the Australian medicines industry has a great tradition in this regard.

“These nominations are testament to the Australian medicines industry as a great place to work, and an industry that values its employees.

“The 14,000 people who work in this industry are ordinary Australians doing extraordinary things, making the medicines and vaccines that save lives, reduce pain and prevent disease.

“It is because the Australian medicines industry is such an engaging and rewarding place to work that we can continue to attract brilliant people to conduct this vital work.

“I congratulate both companies on their accreditation as part of this prestigious awards program.”



Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293


As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at